Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Praill currently holds 47,366 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Praill has been a net buyer of DMPI stock. They have purchased $92.8K and sold $0 worth of shares.
Scott Praill's most recent insider trade was on Oct 5, 2017, when they purchased 17,500 shares at $0.85 per share.
Scott Praill serves as Executive at DelMar Pharmaceuticals, Inc. (DMPI). They have executed 11 insider transactions totaling $92.8K over their tenure at the company.
Scott Praill holds the position of Executive at DelMar Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Scott Praill has shown a buying trading pattern, with $92.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Praill was on Jul 16, 2015, when they purchased $30.0K worth of DMPI shares. This transaction involved 50,000 shares at $0.60 per share.
Scott Praill currently owns 47,366 shares of DelMar Pharmaceuticals, Inc. (DMPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Praill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Praill has 11 Form 4 filings on record as an insider at DelMar Pharmaceuticals, Inc..
Set alerts for Scott Praill and 40,000+ other insiders.